This Day On The Street
Continue to site
ADVERTISEMENT
This account is pending registration confirmation. Please click on the link within the confirmation email previously sent you to complete registration.
Need a new registration confirmation email? Click here

Neuromodulation Devices: World Market Prospects 2013-2023

List of TablesTable 3.1 Net Sales ($bn) and Market Shares (%) Of The Global Medical Market, By Sector, 2011Table 3.2 The Global Neurology Devices Market: Net Sales ($bn) and Market Shares (%), By Speciality, 2011Table 3.3 The Global Neuromodulation Devices Market: Net Sales ($bn) and Market Shares (%), By Technology, 2011Table 3.4 The Global Neuromodulation Devices Market Forecast, By Sector ($bn), 2011-2017Table 3.5 The Global Neuromodulation Devices Market Forecast, By Sector ($bn), 2017-2023Table 4.1 Spinal Cord Stimulation: Market Forecast ($bn), 2011-2017Table 4.2 Spinal Cord Stimulation: Market Forecast ($bn), 2017-2023Table 5.1 Deep Brain Stimulation: Market Forecast ($bn), 2011-2017Table 5.2 Deep Brain Stimulation: Market Forecast ($bn), 2017-2023Table 6.1 Vagus Nerve Stimulation: Market Forecast ($bn), 2011-2017Table 6.2 Vagus Nerve Stimulation: Market Forecast ($bn), 2017-2023Table 7.1 Neuromodulation Devices: Net Sales ($bn) and Market Shares (%), By Company, 2011Table 7.2 Medtronic: Net Sales ($bn) and Market Shares (%), By Segment, 2011Table 7.3 Restorative Therapies: Net Sales ($bn) and Market Shares (%), By Product Line, 2011Table 7.4 Medtronic: Net Sales ($bn) and Market Shares (%), By Region, 2011Table 7.5 SJM: Net Sales ($bn) and Market Shares (%), By Segment, 2011Table 7.6 CRM/NMD Segment: Net Sales ($bn) and Market Shares (%), By Product Group, 2011Table 7.7 SJM: Net Sales ($bn) and Market Shares (%), By Region, 2011Table 7.8 Boston Scientific: Net Sales ($bn) and Market Shares (%), By Product Category, 2011Table 7.9 Boston Scientific: Net Sales ($bn) and Market Shares (%), By Region, 2011Table 7.10 Cyberonics: Net Sales ($m) and Market Shares (%), By Region, 2011Table 7.11 Other Companies Operating in The Global Neuromodulation Device Market, 2012Table 8.1 Neuromodulation Devices: Sales ($bn) and Market Shares (%), By Country/Region, 2011Table 8.2 Neuromodulation Devices Market Forecast ($bn), By Country/Region, 2011-2023Table 8.3 The Leading European Neuromodulation Devices Markets: Market Value ($bn), European Market Shares (%) and Global Market Shares (%), By Region, 2011Table 8.4 The European Neuromodulation Devices Market Forecast ($bn), By Region, 2011-2023Table 9.1 Neuromodulation Devices: Industry Pipeline, 2012Table 10.1 SWOT Analysis of the Neuromodulation Devices Market, 2012Table 12.1 Neuromodulation Devices Market Forecast ($bn) By Technology, in 2017, 2019 and 2023

List of FiguresFigure 3.1 Market Shares (%) Of The Global Medical Device Market, By Sector, 2011Figure 3.2 The Global Neurology Devices Market: Market Shares (%), By Speciality, 2011Figure 3.3 The Global Neuromodulation Devices Market: Net Sales ($bn), By Technology, 2011Figure 3.4 The Global Neuromodulation Devices Market: Market Shares (%), By Technology, 2011Figure 3.5 The Global Neuromodulation Devices Market Forecast, 2011-2017Figure 3.6 The Global Neuromodulation Devices Market Forecast, 2017-2023Figure 4.1 Spinal Cord Stimulation: Market Forecast ($bn), 2011-2017Figure 4.2 Spinal Cord Stimulation: Market Forecast ($bn), 2017-2023Figure 5.1 Deep Brain Stimulation: Market Forecast ($bn), 2011-2017Figure 5.2 Deep Brain Stimulation: Market Forecast ($bn), 2017-2023Figure 6.1 Vagus Nerve Stimulation: Market Forecast ($bn), 2011-2017Figure 6.2 Vagus Nerve Stimulation: Market Forecast ($bn), 2017-2023Figure 7.1 Neuromodulation Devices: Net Sales ($bn), By Company, 2011Figure 7.2 Neuromodulation Devices: Market Shares (%), By Company, 2011Figure 7.3 Medtronic: Market Shares (%), By Segment, 2011Figure 7.4 Restorative Therapies: Net Sales ($bn), By Product Line, 2011Figure 7.5 Restorative Therapies: Market Shares (%), By Product Line, 2011Figure 7.6 Medtronic: Net Sales ($bn), By Region, 2011Figure 7.7 Medtronic: Market Shares (%), By Region, 2011Figure 7.8 SJM: Market Shares (%), By Segment, 2011Figure 7.9 CRM/NMD Segment: Market Shares (%), By Product Group, 2011Figure 7.10 SJM: Net Sales ($bn), By Region, 2011Figure 7.11 SJM: Market Shares (%), By Region, 2011Figure 7.12 Boston Scientific: Net Sales ($bn), By Product Category, 2011Figure 7.13 Boston Scientific: Market Shares (%), By Product Category, 2011Figure 7.14 Boston Scientific: Net Sales ($bn), By Region, 2011Figure 7.15 Boston Scientific: Market Shares (%), By Region, 2011Figure 7.16 Cyberonics: Net Sales ($m), By Quarter, 2011Figure 7.17 Cyberonics: Net Sales ($m), By Region, 2011Figure 7.18 Cyberonics: Market Shares (%), By Region, 2011Figure 8.1 Neuromodulation Devices: Net Sales ($bn), By Region, 2011Figure 8.2 Neuromodulation Devices: Market Shares (%), By Region, 2011Figure 8.3 The US Neuromodulation Devices Market Forecast ($bn), 2011-2023Figure 8.4 The European Neuromodulation Devices Market: Net Sales ($bn), By Region, 2011Figure 8.5 The European Neuromodulation Devices Market: Market Shares (%), By Region, 2011Figure 8.6 The European Neuromodulation Devices Market Forecast ($bn), 2011-2023Figure 8.7 The German Neuromodulation Devices Market Forecast ($bn), 2011-2023Figure 8.8 The French Neuromodulation Devices Market Forecast ($bn), 2011-2023Figure 8.9 The Italian Neuromodulation Devices Market Forecast ($bn), 2011-2023Figure 8.10 The Spanish Neuromodulation Devices Market Forecast ($bn), 2011-2023Figure 8.11 The UK Neuromodulation Devices Market Forecast ($bn), 2011-2023Figure 8.12 The Japanese Neuromodulation Devices Market Forecast ($bn), 2011-2023Figure 8.13 The Chinese Neuromodulation Devices Market Forecast ($bn), 2011-2023Figure 8.14 The Indian Neuromodulation Devices Market Forecast ($bn), 2011-2023Figure 12.1 Projected Neuromodulation Devices Market Size for 2017, 2019 and 2023, By TechnologyFigure 12.2 Projected Total Neuromodulation Devices Market Size ($bn) in 2011, 2017, 2019 and 2023

Companies ListedAdvanced BionicsAleva NeurotherapeuticsApnex MedicalAtrotechAutonomic TechnologiesAvery BiomedicalBioControl MedicalBoston ScientificCerbomedCervel NeurotechCVRxCyberonicsElectroCoreEnteroMedicsFunctional Neuromodulation ImThera MedicalInspire Medical SystemsIntelect MedicalIntraPaceMed-ElMedtronicMetaCureMicroTransponderNeurelecNeuroneticsNeuronix MedicalNeuroPaceNeuros MedicalNeurosigmaNeurotech GroupNeurowave Medical TechnologiesNevroRespicardiaRetina Implant AGRS Medical/Vertis NeuroscienceSecond Sight Medical ProductsSpinal ModulationSPR TherapeuticsSt. Jude MedicalSynapse BiomedicalUroplasty

Government Agencies and Other Organisations Mentioned in This ReportFDAWHOUNEU

To order this report: Pathology Industry: Neuromodulation Devices: World Market Prospects 2013-2023

__________________________Contact Clare: clare@reportlinker.com US:(339) 368 6001 Intl:+1 339 368 6001

SOURCE Reportlinker

Copyright 2011 PR Newswire. All rights reserved. This material may not be published, broadcast, rewritten or redistributed.
2 of 2

Check Out Our Best Services for Investors

Action Alerts PLUS

Portfolio Manager Jim Cramer and Director of Research Jack Mohr reveal their investment tactics while giving advanced notice before every trade.

Product Features:
  • $2.5+ million portfolio
  • Large-cap and dividend focus
  • Intraday trade alerts from Cramer
Quant Ratings

Access the tool that DOMINATES the Russell 2000 and the S&P 500.

Product Features:
  • Buy, hold, or sell recommendations for over 4,300 stocks
  • Unlimited research reports on your favorite stocks
  • A custom stock screener
Stocks Under $10

David Peltier uncovers low dollar stocks with serious upside potential that are flying under Wall Street's radar.

Product Features:
  • Model portfolio
  • Stocks trading below $10
  • Intraday trade alerts
14-Days Free
Only $9.95
14-Days Free
Dividend Stock Advisor

David Peltier identifies the best of breed dividend stocks that will pay a reliable AND significant income stream.

Product Features:
  • Diversified model portfolio of dividend stocks
  • Updates with exact steps to take - BUY, HOLD, SELL
Trifecta Stocks

Every recommendation goes through 3 layers of intense scrutiny—quantitative, fundamental and technical analysis—to maximize profit potential and minimize risk.

Product Features:
  • Model Portfolio
  • Intra Day Trade alerts
  • Access to Quant Ratings
Options Profits

Our options trading pros provide over 100 monthly option trading ideas and strategies to help you become a well-seasoned trader.

Product Features:
  • Actionable options commentary and news
  • Real-time trading community
SYM TRADE IT LAST %CHG

Markets

Chart of I:DJI
DOW 16,654.77 +369.26 2.27%
S&P 500 1,987.66 +47.15 2.43%
NASDAQ 4,812.7080 +115.1720 2.45%

Free Reports

Top Rated Stocks Top Rated Funds Top Rated ETFs